596 related articles for article (PubMed ID: 23386067)
1. Primary venous thromboembolism prophylaxis in ambulatory cancer patients.
Aikens GB; Rivey MP; Hansen CJ
Ann Pharmacother; 2013 Feb; 47(2):198-209. PubMed ID: 23386067
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
3. Risk assessment models for cancer-associated venous thromboembolism.
Dutia M; White RH; Wun T
Cancer; 2012 Jul; 118(14):3468-76. PubMed ID: 22086826
[TBL] [Abstract][Full Text] [Related]
4. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?
Pabinger I; Ay C
Hamostaseologie; 2012; 32(2):132-7. PubMed ID: 21822526
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
[TBL] [Abstract][Full Text] [Related]
7. Rivaroxaban: an oral factor Xa inhibitor.
Thomas TF; Ganetsky V; Spinler SA
Clin Ther; 2013 Jan; 35(1):4-27. PubMed ID: 23328267
[TBL] [Abstract][Full Text] [Related]
8. Does ambulation modify venous thromboembolism risk in acutely ill medical patients?
Amin AN; Girard F; Samama MM
Thromb Haemost; 2010 Nov; 104(5):955-61. PubMed ID: 20838741
[TBL] [Abstract][Full Text] [Related]
9. Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
Merli GJ
Catheter Cardiovasc Interv; 2009 Jul; 74 Suppl 1():S27-34. PubMed ID: 19530157
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
11. New and old anticoagulants in cancer.
Verso M; Agnelli G
Thromb Res; 2012 Apr; 129 Suppl 1():S101-5. PubMed ID: 22682118
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism risk and prophylaxis in hospitalised medically ill patients. The ENDORSE Global Survey.
Bergmann JF; Cohen AT; Tapson VF; Goldhaber SZ; Kakkar AK; Deslandes B; Huang W; Anderson FA;
Thromb Haemost; 2010 Apr; 103(4):736-48. PubMed ID: 20135072
[TBL] [Abstract][Full Text] [Related]
13. Aspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidence.
Stewart DW; Freshour JE
Ann Pharmacother; 2013 Jan; 47(1):63-74. PubMed ID: 23324504
[TBL] [Abstract][Full Text] [Related]
14. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
15. New strategies of VTE prevention in cancer patients.
Verso M; Agnelli G
Thromb Res; 2014 May; 133 Suppl 2():S128-32. PubMed ID: 24862133
[TBL] [Abstract][Full Text] [Related]
16. Risk of venous thromboembolism in patients with chronic liver disease and the utility of venous thromboembolism prophylaxis.
Pincus KJ; Tata AL; Watson K
Ann Pharmacother; 2012 Jun; 46(6):873-8. PubMed ID: 22570429
[TBL] [Abstract][Full Text] [Related]
17. New pharmacologic methods to prevent venous thromboembolism in older adults: a meta-analysis.
Pebanco GD; Kaiser SA; Haines ST
Ann Pharmacother; 2013 May; 47(5):605-16. PubMed ID: 23606553
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism prophylaxis in hospitalized medical patients and those with stroke: a background review for an American College of Physicians Clinical Practice Guideline.
Lederle FA; Zylla D; MacDonald R; Wilt TJ
Ann Intern Med; 2011 Nov; 155(9):602-15. PubMed ID: 22041949
[TBL] [Abstract][Full Text] [Related]
19. Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic options.
Ay C; Pabinger I
Hamostaseologie; 2012; 32(2):139-44. PubMed ID: 21822525
[TBL] [Abstract][Full Text] [Related]
20. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: a review of current guidelines.
Petersen LJ
Cancer Treat Rev; 2009 Dec; 35(8):754-64. PubMed ID: 19762155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
